MC10, a Cambridge, MA-based healthcare technology company, has closed a $2m financing round.
The equity funding was provided by Aberdare Ventures.
Paul Klingenstein, managing partner at Aberdare Ventures, jas joined the company’s board of directors.
Led by CEO David Icke, MC10 is developing a variety of products including interventional circuits that can diagnose and influence tissue function and seamless sensing devices that can monitor key aspects of performance such as the heart (ECG), the brain (EEG), muscles (EMG), body temperature, and hydration.
The company is hiring (http://mc10inc.com/pages/co_careers).